Table 1 Comparing of clinical features between cervical gastric-type and non-gastric type adenocarcinoma
Clinical features | GAS | Non-GAS | P value |
|---|---|---|---|
Age (median, IQR) | 46 (41.8,59.3) | 48 (40.5,59.0) | 0.93 |
Symptoms (n, %) | 0.04 | ||
Bleeding | 18 (66.7%) | 14 (100%) | |
Watery discharge | 9 (33.3%) | 0 (0%) | |
Tumor Size in the largest dimension (n, %) | 0.24 | ||
< 4 cm | 21 (55.3%) | 13 (76.5%) | |
≥ 4 cm | 17 (44.7%) | 4 (23.5%) | |
TCT (n, %) | 0.87 | ||
NILM | 10 (38.5%) | 4 (44.4%) | |
Abnormal | 16 (61.5%) | 5 (55.6%) | |
Stage (n, %) | 0.036 | ||
I-IIA | 17 (46.0%) | 11 (84.6%) | |
IIB-IV | 20 (54.0%) | 2 (15.4%) | |
Lymph nodes metastasis (n, %) | 0.23 | ||
Negative | 24 (70.6%) | 12 (92.3%) | |
Positive | 10 (29.4%) | 1 (7.7%) | |
Deep stromal invasion (n, %) | 0.002 | ||
Negative | 4 (11.8%) | 8 (61.5%) | |
Positive | 30 (88.2%) | 5 (38.5%) | |
LVSI (n, %) | 0.044 | ||
Negative | 19 (55.9%) | 12 (92.3%) | |
Positive | 15 (44.1%) | 1 (7.7%) |